SCHEMBL1590856

SCHEMBL1590856

O=S(=O)(Nc1nccc2ccccc12)c1c(Cl)nc2n1CCS2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.53
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR1A P08908 1/20 0.36
HTR2A P28223 1/20 0.36
HTR7 P34969 1/20 0.36
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
DRD4 P21917 1/20 0.35
FDPS P14324 1/20 0.35
CNR2 P34972 1/20 0.35
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
USP30 Q70CQ3 1/20 0.34
ADRA1A P35348 1/20 0.34
KCNH2 Q12809 1/20 0.34
HRH4 Q9H3N8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591407 0.78 HTR6 (0.57) HTR6MAPTPOLBTDP1ALDH1A1
SCHEMBL1880552 0.77 ACLY (0.52) HTR6HTR2AHTR7ADRA1A
Hydrochloric Acid SCHEMBL1590775 0.72 HTR6 (0.49) HTR6MAPTPOLBTDP1ALDH1A1
SCHEMBL1590988 0.71 ALDH1A1 (0.51) HTR6POLBALDH1A1LMNAHTT
SCHEMBL1590132 0.70 HTR6 (0.67) HTR6POLBHTR2ADRD2DRD3
SCHEMBL1591157 0.70 HTR6 (0.49) HTR6MAPTPOLBTDP1ALDH1A1
SCHEMBL1590499 0.70 HTR6 (0.63) HTR6SMN1; SMN2
Hydrochloric Acid SCHEMBL1590417 0.70 HTR6 (0.46) HTR6TNKS2TNKS
SCHEMBL1590334 0.69 HTR6 (1.00) HTR6MAPTPOLBALDH1A1LMNA
SCHEMBL12702633 0.68 HTR6 (0.73) HTR6POLBTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS HTR6, HTR2A, HTR4 HTR6 1/4885MAPT 1860/4885POLB 3975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.